Fresolimumab
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Maximilian Diehn
Overview
Fresolimumab is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Fresolimumab clinical trials
Explore related
Medical disclaimer. This page summarizes research about Fresolimumab for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.